Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-Hormone Closed-Loop Glucose Control in Type 1 Diabetes
2014-003261-20Phase 4Terminated
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin aspart and glucagon in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Percentage of time with glucose values < 3.9 mmol/l. Started Oct 2014; status: terminated.
02
Drugs
insulin aspartglucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-003261-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003261-20.